logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > China Stock

Hangzhou Todaytec Digital (300743.SZ) shareholder Li Zhuoya has completed the reduction of 724,600 shares.

date
21:01 08/01/2025
avatar
GMT Eight
Tianqi Digital (300743.SZ) announcement, company shareholder Li Zhuoya accumulated reduction of 724,600 shares of the company...
Hangzhou Todaytec Digital (300743.SZ) announced that company shareholder Li Zhuoya has decreased her holdings of the company's shares by a total of 724,600 shares, accounting for 0.48% of the total share capital. The reduction plan has now been completed.
Related Articles
HK Stock
TIANJIN DEV (00882): Tianjin Lisheng Pharmaceutical reported a mid-term net profit attributable to shareholders of 78.326 million yuan, a year-on-year decrease of 77.16%.
HK Stock
LONGBIO-B(01779): The Biologics License Application (BLA) for LP-003 targeting seasonal allergic rhinitis has been accepted by the National Medical Products Administration.
HK Bull/Bear Outstanding Qty Ratio(51:49) | August 21
TIANJIN DEV (00882): Tianjin Lisheng Pharmaceutical reported a mid-term net profit attributable to shareholders of 78.326 million yuan, a year-on-year decrease of 77.16%.
HK Stock
LONGBIO-B(01779): The Biologics License Application (BLA) for LP-003 targeting seasonal allergic rhinitis has been accepted by the National Medical Products Administration.
HK Stock
HK Bull/Bear Outstanding Qty Ratio(51:49) | August 21
RECOMMEND
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
icon
10/06/2026
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
icon
10/06/2026
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
icon
10/06/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.